Martín
Lazaro Quintela
![Foto de Martín](/img/nophoto.png)
![Foto de Zhejiang Cancer Hospital](/img/noimage_org.png)
Zhejiang Cancer Hospital
Hangzhou, ChinaPublicacións en colaboración con investigadores/as de Zhejiang Cancer Hospital (1)
2020
-
Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial
The Lancet Respiratory Medicine, Vol. 8, Núm. 11, pp. 1132-1143